全文获取类型
收费全文 | 3967篇 |
免费 | 336篇 |
国内免费 | 30篇 |
专业分类
耳鼻咽喉 | 68篇 |
儿科学 | 118篇 |
妇产科学 | 110篇 |
基础医学 | 484篇 |
口腔科学 | 114篇 |
临床医学 | 582篇 |
内科学 | 961篇 |
皮肤病学 | 112篇 |
神经病学 | 235篇 |
特种医学 | 331篇 |
外科学 | 367篇 |
综合类 | 110篇 |
一般理论 | 1篇 |
预防医学 | 329篇 |
眼科学 | 10篇 |
药学 | 174篇 |
中国医学 | 5篇 |
肿瘤学 | 222篇 |
出版年
2023年 | 15篇 |
2022年 | 14篇 |
2021年 | 48篇 |
2020年 | 25篇 |
2019年 | 62篇 |
2018年 | 75篇 |
2017年 | 41篇 |
2016年 | 44篇 |
2015年 | 60篇 |
2014年 | 83篇 |
2013年 | 121篇 |
2012年 | 145篇 |
2011年 | 176篇 |
2010年 | 111篇 |
2009年 | 107篇 |
2008年 | 139篇 |
2007年 | 168篇 |
2006年 | 164篇 |
2005年 | 174篇 |
2004年 | 156篇 |
2003年 | 156篇 |
2002年 | 156篇 |
2001年 | 156篇 |
2000年 | 134篇 |
1999年 | 137篇 |
1998年 | 103篇 |
1997年 | 117篇 |
1996年 | 113篇 |
1995年 | 78篇 |
1994年 | 78篇 |
1993年 | 76篇 |
1992年 | 126篇 |
1991年 | 63篇 |
1990年 | 81篇 |
1989年 | 104篇 |
1988年 | 100篇 |
1987年 | 73篇 |
1986年 | 80篇 |
1985年 | 88篇 |
1984年 | 48篇 |
1983年 | 40篇 |
1982年 | 33篇 |
1981年 | 28篇 |
1980年 | 34篇 |
1979年 | 30篇 |
1978年 | 23篇 |
1977年 | 23篇 |
1976年 | 21篇 |
1975年 | 20篇 |
1968年 | 15篇 |
排序方式: 共有4333条查询结果,搜索用时 0 毫秒
1.
R H Green C E Brightling S McKenna B Hargadon N Neale D Parker C Ruse I P Hall I D Pavord 《The European respiratory journal》2006,27(6):1144-1151
There is increasing evidence that the assessment of eosinophilic airway inflammation using induced sputum and measurement of airway hyperresponsiveness provides additional, clinically important information concerning asthma control. The aim of this study was to directly compare the effects of different treatments on these markers in patients with asthma and persistent symptoms, despite the use of low-dose inhaled corticosteroids. A double-blind four-way crossover study was performed, which compared a 1-month treatment with budesonide 400 mug b.i.d., additional formoterol, additional montelukast and placebo in 49 patients with uncontrolled asthma despite budesonide 100 mug b.i.d., with each treatment separated by a 4-week washout period. The change in sputum eosinophil count with formoterol (2.4 to 3.8% change, 0.6-fold reduction, 95% confidence interval (CI) 0.5-0.9) differed significantly from placebo (2.8 to 2.5% change, 1.1-fold reduction, 95% CI 0.7-1.6) and high-dose budesonide (2.7 to 1.6% change, 1.6-fold reduction, 95% CI 1.2-2.2). The effects of montelukast did not differ from placebo. The changes in methacholine airway responsiveness were small and did not differ between treatments. High-dose budesonide had the broadest range of beneficial effects on other outcomes, including symptom scores, morning peak expiratory flow and forced expiratory volume in one second. In conclusion, treatment given in addition to low-dose inhaled corticosteroids results in modest benefits. Formoterol and high-dose budesonide have contrasting effects on eosinophilic airway inflammation. 相似文献
2.
3.
Sonoelasticity imaging of prostate cancer: in vitro results 总被引:2,自引:0,他引:2
4.
5.
H. -J. Möller H. M. van Praag B. Aufdembrinke P. Bailey T. R. E. Barnes J. Beck H. Bentsen F. X. Eich L. Farrow W. W. Fleischhacker J. Gerlach K. Grafford B. Hentschel A. Hertkorn S. Heylen Y. Lecrubier J. P. Leonard P. McKenna W. Maier V. Pedersen A. Rappard W. Rein J. Ryan M. Sloth Nielsen R. -D. Stieglitz G. Wegener J. Wilson 《Psychopharmacology》1994,115(1-2):221-228
There is little agreement about the methodology of clinical trials of antipsychotic drugs in patients with negative symptoms. A literature review revealed wide variation in experimental design, rating scales and study duration. This reflects differing views as to the definition and response to treatment of negative symptoms. Some degree of standardization would improve comparability of studies and aid the development of new compounds. Patients included in such studies should have displayed negative symptoms for at least 6 months. Depressive symptoms, positive schizophrenic symptoms and extrapyramidal signs may all influence or be confused with negative symptoms and may respond to treatment; they should be at a low level at baseline and should be measured during the study period. Studies should last at least 8 weeks. Several scales are available for measuring negative symptoms and are reviewed; a global impression score should be used additionally. 相似文献
6.
7.
8.
9.
10.